Kestra Medical Technologies Ltd

KMTS

Add to Watchlist

19.820USD

-2.250-10.19%

Close 05/15, 16:00（ET）Quotes delayed by 15 min

Kestra Medical Technologies Ltd's Score

Industry at a Glance

Industry Ranking

32 / 206

Overall Ranking

108 / 4482

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Positive

Kestra Medical Technologies Ltd Highlights

StrengthsRisks

Kestra Medical Technologies, Ltd. is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intelligent and connected. The Company has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The Company's Cardiac Recovery System platform includes ASSURE WCD, which is a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). Its Cardiac Recovery System platform also includes fully integrated digital solutions and services such as the ASSURE patient application, Kestra CareStation remote patient data platform, Heart Alert Services, and ASSURE Assist services and ASSURE wearable ECG.

Growing

The company is in a growing phase, with the latest annual income totaling USD 59.81M.

Overvalued

The company’s latest PE is -6.90, at a high 3-year percentile range.

Institutional Buying

The latest institutional holdings are 60.76M shares, increasing 8.58% quarter-over-quarter.

Held by Invesco

Star Investor Invesco holds 3.76K shares of this stock.

Analyst Rating

Based on 7 analysts

Buy

Current Rating

27.400

Target Price

+24.15%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current financial score of Kestra Medical Technologies Ltd is 7.94, ranking 52 out of 206 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 24.55M, representing a year-over-year increase of 62.70%, while its net profit experienced a year-over-year increase of 37.58%.

Score

Industry at a Glance

Previous score

7.94

Change

0



Financials

8.01

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

7.33

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

10.00

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

7.12

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.24

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

The current valuation score of Kestra Medical Technologies Ltd is 7.29, ranking 96 out of 206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -6.90, which is -19.39% below the recent high of -5.56 and -55.89% above the recent low of -10.75.

Score

Industry at a Glance

Previous score

7.29

Change

0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 32/206

Relevant data have not been disclosed by the company yet.

The current earnings forecast score of Kestra Medical Technologies Ltd is 8.86, ranking 14 out of 206 in the Healthcare Equipment & Supplies industry. The average price target is 28.00, with a high of 32.00 and a low of 22.00.

Score

Industry at a Glance

Previous score

8.86

Change

0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current price momentum score of Kestra Medical Technologies Ltd is 6.58, ranking 119 out of 206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 23.23 and the support level at 17.71, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

7.24

Change

-0.66

Support & Resistance

Relevant data have not been disclosed by the company yet.

Institutional Confidence

Currency: USD Updated: 2026-05-15

The current institutional shareholding score of Kestra Medical Technologies Ltd is 10.00, ranking 1 out of 206 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 104.08%, representing a quarter-over-quarter increase of 20.41%. The largest institutional shareholder is PRFDX, holding a total of 5.97M shares, representing 10.22% of shares outstanding, with 518.12% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Bain Capital Private Equity, LP

25.17M

-6.84%

T. Rowe Price Associates, Inc.

Star Investors

4.34M

+138.90%

Fidelity Management & Research Company LLC

5.05M

+16.10%

Andera Partners S.A.S.

2.54M

--

Endeavour Medtech Growth II LP

2.45M

-7.48%

Ally Bridge Group (HK) Limited

2.28M

--

Brown Advisory

1.69M

+34.06%

AllianceBernstein L.P.

1.43M

-4.42%

Omega Fund Management, LLC

1.37M

-16.54%

Eventide Asset Management, LLC

1.27M

+5.42%



1

2



The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Kestra Medical Technologies Ltd is 4.68, ranking 98 out of 206 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.

Kestra Medical Technologies Ltd

KMTS

7.63 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Lantheus Holdings Inc

LNTH

8.68 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Anika Therapeutics Inc

ANIK

8.58 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

LivaNova PLC

LIVN

8.37 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Thermo Fisher Scientific Inc

TMO

8.35 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Bruker Corp

BRKR

8.23 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment